{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:40:23Z","timestamp":1761007223412,"version":"build-2065373602"},"reference-count":130,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.soc.2019.06.010","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T17:24:06Z","timestamp":1564766646000},"page":"763-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Expanding the Surgical Pool for Hepatic Resection to Treat Biliary and Primary Liver Tumors"],"prefix":"10.1016","volume":"28","author":[{"given":"Tiffany C.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mackenzie C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimul A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.soc.2019.06.010_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/jhbp.568","article-title":"Preoperative assessment of frailty predicts age-related events after hepatic resection: a prospective multicenter study","volume":"25","author":"Tanaka","year":"2018","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib2","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s11605-017-3373-6","article-title":"Frailty as a risk predictor of morbidity and mortality following liver surgery","volume":"21","author":"Gani","year":"2017","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib3","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.surg.2017.07.019","article-title":"Nomograms for prediction of long-term survival in elderly patients after partial hepatectomy for hepatocellular carcinoma","volume":"162","author":"Cheng","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2019.06.010_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijsu.2016.02.060","article-title":"Liver resection in the elderly: a retrospective cohort study of 460 patients\u2013feasible and safe","volume":"28","author":"Andert","year":"2016","journal-title":"Int J Surg"},{"issue":"7","key":"10.1016\/j.soc.2019.06.010_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00595-014-0994-1","article-title":"Hepatic resection for hepatocellular carcinoma in super-elderly patients aged 80 years and older in the first decade of the 21st century","volume":"45","author":"Nozawa","year":"2015","journal-title":"Surg Today"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1245\/s10434-010-1404-6","article-title":"Safety of liver resection in the elderly: how important is age?","volume":"18","author":"Cho","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.soc.2019.06.010_bib7","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s00268-008-9688-4","article-title":"Hepatic resection is justified for elderly patients with hepatocellular carcinoma","volume":"32","author":"Kondo","year":"2008","journal-title":"World J Surg"},{"issue":"9","key":"10.1016\/j.soc.2019.06.010_bib8","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s11605-009-0933-4","article-title":"Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy","volume":"13","author":"Huang","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s11605-008-0758-6","article-title":"Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more","volume":"13","author":"Oishi","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"12","key":"10.1016\/j.soc.2019.06.010_bib10","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/hpb.12312","article-title":"Is liver transplantation safe and effective in elderly (\u226570 years) recipients? A case-controlled analysis","volume":"16","author":"Wilson","year":"2014","journal-title":"HPB (Oxford)"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib11","first-page":"557","article-title":"The elderly liver transplant recipients: anxiety, depression, fatigue and life satisfaction","volume":"55","author":"Krenzien","year":"2017","journal-title":"Z\u00a0Gastroenterol"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib12","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/j.gastro.2007.01.040","article-title":"Risk factors for mortality after surgery in patients with cirrhosis","volume":"132","author":"Teh","year":"2007","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib13","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0039-6060(97)90080-5","article-title":"Abdominal operations in patients with cirrhosis: still a major surgical challenge","volume":"122","author":"Mansour","year":"1997","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.soc.2019.06.010_bib14","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1053\/j.gastro.2008.02.091","article-title":"Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma","volume":"134","author":"Ishizawa","year":"2008","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.soc.2019.06.010_bib15","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.gassur.2005.09.008","article-title":"Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage liver disease (MELD) score predicts perioperative mortality","volume":"9","author":"Teh","year":"2005","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.soc.2019.06.010_bib16","first-page":"192","article-title":"Surgery in the patient with liver disease","volume":"121","author":"Friedman","year":"2010","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"2","key":"10.1016\/j.soc.2019.06.010_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00268-004-7633-8","article-title":"A\u00a0critical evaluation of hepatic resection in\u00a0cirrhosis: optimizing patient selection and outcomes","volume":"29","author":"Emond","year":"2005","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib18","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00000658-200211000-00010","article-title":"Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified?","volume":"236","author":"Poon","year":"2002","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S0016-5085(96)70070-7","article-title":"Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure","volume":"111","author":"Bruix","year":"1996","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00042737-200505000-00005","article-title":"Surgical therapy of hepatocellular carcinoma","volume":"17","author":"McCormack","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.soc.2019.06.010_bib21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib22","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jhep.2014.10.037","article-title":"Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study","volume":"62","author":"Vitale","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2014.03.012","article-title":"Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT","volume":"61","author":"Yin","year":"2014","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","article-title":"A\u00a0snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations?: an observational study of the HCC East-West study group","volume":"257","author":"Torzilli","year":"2013","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1067\/msy.2000.105294","article-title":"Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations","volume":"127","author":"Vauthey","year":"2000","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.soc.2019.06.010_bib27","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1245\/s10434-012-2450-z","article-title":"A\u00a0comprehensive meta-regression analysis on outcome of anatomic resection versus nonanatomic resection for hepatocellular carcinoma","volume":"19","author":"Cucchetti","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"128","key":"10.1016\/j.soc.2019.06.010_bib28","first-page":"2019","article-title":"Anatomic versus non-anatomic liver resection for hepatocellular carcinoma: a systematic review","volume":"60","author":"Tang","year":"2013","journal-title":"Hepatogastroenterology"},{"issue":"19","key":"10.1016\/j.soc.2019.06.010_bib29","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib32","first-page":"324","article-title":"Effective ways to improve the prognosis of advanced stage (BCLC stage C) hepatocellular carcinoma","volume":"53","author":"Cheng","year":"2015","journal-title":"Zhonghua Wai Ke Za Zhi"},{"issue":"13","key":"10.1016\/j.soc.2019.06.010_bib33","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol"},{"issue":"32","key":"10.1016\/j.soc.2019.06.010_bib34","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1200\/JCO.2012.45.8372","article-title":"Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial","volume":"31","author":"Cheng","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"28","key":"10.1016\/j.soc.2019.06.010_bib35","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1200\/JCO.2012.48.4410","article-title":"Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study","volume":"31","author":"Johnson","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"28","key":"10.1016\/j.soc.2019.06.010_bib36","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1200\/JCO.2012.47.3009","article-title":"Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study","volume":"31","author":"Llovet","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2019.06.010_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1200\/JCO.2013.54.3298","article-title":"Linifanib versus Sorafenib in patients with advanced hepatocellular carcinoma: results of a randomized phase III trial","volume":"33","author":"Cainap","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"10126","key":"10.1016\/j.soc.2019.06.010_bib38","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.soc.2019.06.010_bib39","doi-asserted-by":"crossref","first-page":"E718","DOI":"10.1111\/ans.14387","article-title":"Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma","volume":"88","author":"Lin","year":"2018","journal-title":"ANZ J Surg"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib40","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000102901","article-title":"Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma","volume":"24","author":"Chen","year":"2007","journal-title":"Dig Surg"},{"key":"10.1016\/j.soc.2019.06.010_bib41","article-title":"Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC","volume":"37","author":"Kaseb AOP","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib42","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/BF01655244","article-title":"Preoperative portal vein embolization for hepatocellular carcinoma","volume":"10","author":"Kinoshita","year":"1986","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.soc.2019.06.010_bib43","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2168.2001.01658.x","article-title":"Portal vein embolization: rationale, technique and future prospects","volume":"88","author":"Abdalla","year":"2001","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archsurg.137.6.675","article-title":"Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization","volume":"137","author":"Abdalla","year":"2002","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/SLA.0b013e31815f6e5b","article-title":"Preoperative portal vein embolization for major liver resection: a meta-analysis","volume":"247","author":"Abulkhir","year":"2008","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib46","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jamcollsurg.2014.04.022","article-title":"Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure","volume":"219","author":"Leung","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"issue":"11","key":"10.1016\/j.soc.2019.06.010_bib47","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/bjs.5836","article-title":"Portal vein embolization before major\u00a0hepatectomy and its effects on regeneration, resectability and outcome","volume":"94","author":"Ribero","year":"2007","journal-title":"Br J Surg"},{"issue":"3\u20134","key":"10.1016\/j.soc.2019.06.010_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000343829","article-title":"Portal vein embolization for hepatocellular carcinoma","volume":"1","author":"Shindoh","year":"2012","journal-title":"Liver Cancer"},{"issue":"9","key":"10.1016\/j.soc.2019.06.010_bib49","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/1097-0142(20011101)92:9<2384::AID-CNCR1586>3.0.CO;2-H","article-title":"Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma?","volume":"92","author":"Wakabayashi","year":"2001","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib50","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.surg.2008.10.009","article-title":"Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival","volume":"145","author":"Palavecino","year":"2009","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.soc.2019.06.010_bib51","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1046\/j.1365-2168.2000.01438.x","article-title":"Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function","volume":"87","author":"Tanaka","year":"2000","journal-title":"Br J Surg"},{"issue":"7","key":"10.1016\/j.soc.2019.06.010_bib52","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archsurg.139.7.766","article-title":"Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma","volume":"139","author":"Aoki","year":"2004","journal-title":"Arch Surg"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib53","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1245\/s10434-010-1423-3","article-title":"Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma","volume":"18","author":"Yoo","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.soc.2019.06.010_bib54","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/bjs.5341","article-title":"Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma","volume":"93","author":"Ogata","year":"2006","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib55","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1245\/s10434-017-5800-z","article-title":"Efficacy of preoperative portal vein embolization among patients with hepatocellular carcinoma, biliary tract cancer, and colorectal liver metastases: a comparative study based on single-center experience of 319 cases","volume":"24","author":"Yamashita","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000335718","article-title":"Portal vein embolization before extended hepatectomy for biliary cancer: current technique and review of 494 consecutive embolizations","volume":"29","author":"Ebata","year":"2012","journal-title":"Dig Surg"},{"issue":"2","key":"10.1016\/j.soc.2019.06.010_bib57","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jhep.2011.07.012","article-title":"Radioembolization for hepatocellular carcinoma","volume":"56","author":"Sangro","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib58","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jhep.2013.06.015","article-title":"Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection","volume":"59","author":"Vouche","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"8","key":"10.1016\/j.soc.2019.06.010_bib59","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1245\/s10434-013-2906-9","article-title":"Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting?","volume":"20","author":"Edeline","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib60","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/hep.26947","article-title":"Left-liver hypertrophy after therapeutic right-liver radioembolization is substantial but less than after portal vein embolization","volume":"59","author":"Garlipp","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib61","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","article-title":"Right portal vein ligation combined with in\u00a0situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings","volume":"255","author":"Schnitzbauer","year":"2012","journal-title":"Ann Surg"},{"issue":"13","key":"10.1016\/j.soc.2019.06.010_bib62","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/bjs.10290","article-title":"Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy","volume":"103","author":"Eshmuminov","year":"2016","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib63","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s00268-014-2513-3","article-title":"ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis","volume":"38","author":"Schadde","year":"2014","journal-title":"World J Surg"},{"issue":"9","key":"10.1016\/j.soc.2019.06.010_bib64","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1245\/s10434-014-4213-5","article-title":"Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy","volume":"22","author":"Schadde","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib65","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1097\/SLA.0b013e318265fd3e","article-title":"Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost?","volume":"256","author":"Aloia","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.soc.2019.06.010_bib66","article-title":"Associating liver partition and portal vein ligation for staged hepatectomy for unresectable hepatitis B virus-related hepatocellular carcinoma: a single center study of 45 patients","author":"Wang","year":"2018","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib67","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s11605-018-3697-x","article-title":"ALPPS for hepatocellular carcinoma is associated with decreased liver remnant growth","volume":"22","author":"Chia","year":"2018","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.soc.2019.06.010_bib68","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijsu.2016.04.031","article-title":"ALPPS for primary and secondary liver tumors","volume":"30","author":"Vennarecci","year":"2016","journal-title":"Int J Surg"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s13304-018-0596-3","article-title":"The ALPPS procedure: hepatocellular carcinoma as a main indication. An Italian single-center experience","volume":"71","author":"Vennarecci","year":"2019","journal-title":"Updates Surg"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib70","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1245\/s10434-015-5007-0","article-title":"Should ALPPS be used for liver resection in intermediate-stage HCC?","volume":"23","author":"D'Haese","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib71","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.hpb.2016.10.008","article-title":"High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry","volume":"19","author":"Olthof","year":"2017","journal-title":"HPB (Oxford)"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib72","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.hpb.2017.01.024","article-title":"Outcome of ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry","volume":"19","author":"Lang","year":"2017","journal-title":"HPB (Oxford)"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib73","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/SLA.0000000000001633","article-title":"ALPPS\u2013where do we stand, where do we go?: eight recommendations from the First International Expert Meeting","volume":"263","author":"Oldhafer","year":"2016","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.soc.2019.06.010_bib74","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib75","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<538::AID-CNCR7>3.0.CO;2-H","article-title":"Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?","volume":"88","author":"Marsh","year":"2000","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib76","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib77","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/SLA.0b013e318148c704","article-title":"Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA","volume":"246","author":"Duffy","year":"2007","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","article-title":"Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis","volume":"10","author":"Mazzaferro","year":"2009","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib79","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000106910","article-title":"Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series","volume":"25","author":"Sugawara","year":"2007","journal-title":"Dig Dis"},{"issue":"12","key":"10.1016\/j.soc.2019.06.010_bib80","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1097\/TP.0b013e31816b67e4","article-title":"Liver transplantation for hepatocellular carcinoma: Hangzhou experiences","volume":"85","author":"Zheng","year":"2008","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib81","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/gutjnl-2014-308513","article-title":"Liver transplantation for hepatocellular carcinoma beyond the Milan criteria","volume":"65","author":"Xu","year":"2016","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.soc.2019.06.010_bib82","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s11605-012-2019-y","article-title":"Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies","volume":"16","author":"Lei","year":"2012","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib83","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/hep.27752","article-title":"Downstaging of hepatocellular cancer before liver transplant: long-term outcome compared to tumors within Milan criteria","volume":"61","author":"Yao","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib84","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0168-8278(98)80123-2","article-title":"Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?","volume":"29","author":"Oldhafer","year":"1998","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib85","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00000658-199712000-00006","article-title":"Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis","volume":"226","author":"Majno","year":"1997","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib86","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/SLA.0b013e31818a07d4","article-title":"Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation","volume":"248","author":"Chapman","year":"2008","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.soc.2019.06.010_bib87","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.jvir.2013.07.024","article-title":"Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization","volume":"24","author":"Green","year":"2013","journal-title":"J\u00a0Vasc Interv Radiol"},{"issue":"4 Pt 1","key":"10.1016\/j.soc.2019.06.010_bib88","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1600-6143.2005.00750.x","article-title":"The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma","volume":"5","author":"Yao","year":"2005","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.soc.2019.06.010_bib89","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.24169","article-title":"Downstaging hepatocellular carcinoma: a systematic review and pooled analysis","volume":"21","author":"Parikh","year":"2015","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib90","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.surg.2017.08.007","article-title":"Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria","volume":"162","author":"Kim","year":"2017","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib91","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.cgh.2017.11.037","article-title":"Excellent outcomes of liver transplantation following down-staging of hepatocellular carcinoma to within milan criteria: a multicenter study","volume":"16","author":"Mehta","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.soc.2019.06.010_bib92","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/lt.24955","article-title":"Current status of liver transplantation for cholangiocarcinoma","volume":"24","author":"Goldaracena","year":"2018","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib93","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.surg.2017.03.017","article-title":"Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: outcome analysis and prognostic factors","volume":"162","author":"Kimura","year":"2017","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib94","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib95","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s00268-007-9001-y","article-title":"Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications","volume":"31","author":"Hasegawa","year":"2007","journal-title":"World J Surg"},{"issue":"9","key":"10.1016\/j.soc.2019.06.010_bib96","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/annonc\/mdv279","article-title":"Survival after resection of perihilar cholangiocarcinoma\u2013development and external validation of a prognostic nomogram","volume":"26","author":"Groot Koerkamp","year":"2015","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib97","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1634\/theoncologist.2-3-164","article-title":"Indications and role of liver transplantation for malignant tumors","volume":"2","author":"Pichlmayr","year":"1997","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib98","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/lv.2000.6143","article-title":"Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma","volume":"6","author":"De Vreede","year":"2000","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.soc.2019.06.010_bib99","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2004-828896","article-title":"Liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"24","author":"Heimbach","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib100","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib101","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12\u00a0US centers","volume":"143","author":"Darwish Murad","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib102","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/SLA.0000000000002574","article-title":"Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease","volume":"267","author":"Ethun","year":"2018","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.soc.2019.06.010_bib103","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/hpb.12450","article-title":"Hilar cholangiocarcinoma: expert consensus statement","volume":"17","author":"Mansour","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"12 Suppl 3","key":"10.1016\/j.soc.2019.06.010_bib104","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1002\/lt.20965","article-title":"Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia","volume":"12","author":"Gores","year":"2006","journal-title":"Liver Transpl"},{"issue":"11","key":"10.1016\/j.soc.2019.06.010_bib105","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/lt.20512","article-title":"Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience","volume":"11","author":"Ghali","year":"2005","journal-title":"Liver Transpl"},{"issue":"9","key":"10.1016\/j.soc.2019.06.010_bib106","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1016\/j.transproceed.2008.08.053","article-title":"Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience","volume":"40","author":"Sotiropoulos","year":"2008","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib107","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/TP.0000000000000286","article-title":"Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation","volume":"99","author":"Facciuto","year":"2015","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib108","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/hep.28744","article-title":"Liver transplantation for \"very early\" intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment","volume":"64","author":"Sapisochin","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib109","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/lt.25052","article-title":"Liver transplantation for intrahepatic cholangiocarcinoma","volume":"24","author":"Lee","year":"2018","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib110","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S2468-1253(18)30045-1","article-title":"Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series","volume":"3","author":"Lunsford","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib111","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/jso.23531","article-title":"Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times","volume":"109","author":"Squires","year":"2014","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib112","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/SLA.0b013e31822ca66f","article-title":"Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?","volume":"254","author":"Koniaris","year":"2011","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib113","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/jso.21415","article-title":"Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma","volume":"101","author":"Lee","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib114","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1477-2574.2009.00073.x","article-title":"Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria","volume":"11","author":"Facciuto","year":"2009","journal-title":"HPB (Oxford)"},{"issue":"3","key":"10.1016\/j.soc.2019.06.010_bib115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1432-2277.2007.00597.x","article-title":"Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma","volume":"21","author":"Baccarani","year":"2008","journal-title":"Transpl Int"},{"issue":"10","key":"10.1016\/j.soc.2019.06.010_bib116","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s11605-008-0652-2","article-title":"Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?","volume":"12","author":"Bellavance","year":"2008","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib117","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1600-6143.2008.02229.x","article-title":"Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience","volume":"8","author":"Del Gaudio","year":"2008","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib118","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1600-6143.2006.01719.x","article-title":"Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria","volume":"7","author":"Cillo","year":"2007","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.soc.2019.06.010_bib119","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1245\/s10434-007-9443-3","article-title":"An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution","volume":"14","author":"Shah","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.sla.0000225255.01668.65","article-title":"Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: impact on long-term survival","volume":"245","author":"Poon","year":"2007","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.soc.2019.06.010_bib121","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/lt.20398","article-title":"Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation","volume":"11","author":"Margarit","year":"2005","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib122","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/jlts.2003.50070","article-title":"Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation","volume":"9","author":"Bigourdan","year":"2003","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.soc.2019.06.010_bib123","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.sla.0000090449.87109.44","article-title":"Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?","volume":"238","author":"Adam","year":"2003","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.soc.2019.06.010_bib124","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/BF02557525","article-title":"Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients","volume":"9","author":"Shabahang","year":"2002","journal-title":"Ann Surg Oncol"},{"issue":"1\u20132","key":"10.1016\/j.soc.2019.06.010_bib125","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0041-1345(00)02550-1","article-title":"Treatment of HCC: the role of liver resection in the era of transplantation","volume":"33","author":"De Carlis","year":"2001","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib126","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S1072-7515(00)00251-9","article-title":"Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy","volume":"190","author":"Figueras","year":"2000","journal-title":"J\u00a0Am Coll Surg"},{"issue":"6","key":"10.1016\/j.soc.2019.06.010_bib127","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/hep.510300629","article-title":"Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation","volume":"30","author":"Llovet","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib128","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/lt.23757","article-title":"Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma","volume":"20","author":"Welling","year":"2014","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.soc.2019.06.010_bib129","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/lt.22462","article-title":"Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma","volume":"18","author":"Panjala","year":"2012","journal-title":"Liver Transpl"},{"issue":"1","key":"10.1016\/j.soc.2019.06.010_bib130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/hpb.12082","article-title":"Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience","volume":"16","author":"Duignan","year":"2014","journal-title":"HPB (Oxford)"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320719300523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320719300523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:06:21Z","timestamp":1760961981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320719300523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":130,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1055320719300523"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2019.06.010","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding the Surgical Pool for Hepatic Resection to Treat Biliary and Primary Liver Tumors","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2019.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}